Articles about 'Cambridge Enterprise'

One in 200 newborns is admitted to a neonatal unit with sepsis caused by a bacteria commonly carried by their mothers – much greater than the previous estimate, say Cambridge researchers. The team has developed an ultra-sensitive test capable of better detecting the bacteria, as it is missed in the vast majority of cases.

Researchers have developed a new way of improving diagnosis of bipolar disorder that uses a simple blood test to identify biomarkers associated with the condition.

 An ambitious new strategy to nurture and grow its innovation ecosystem has been unveiled at Cambridge summit.

Studies of a ‘future-proof’ vaccine candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals. The studies suggest that a single vaccine with combinations of these antigens – a substance that causes the immune system to produce antibodies against it – could protect against an even greater range of current and future coronaviruses.

Cambridge remains the most intensive science and technological cluster in the world – according to a new report ranking innovation around the globe.

Apollo Therapeutics, a biopharmaceutical company originally set up by three UK universities (Cambridge, Imperial College London and University College London) and three pharmaceutical companies (AstraZeneca, GSK and Johnson & Johnson Innovation), has secured $226.5 million venture capital financing.

Co-founder and CEO of Start Codon, Jason Mellad on helping healthcare start-ups thrive and why inclusion and diversity will change the world.

Cambridge Enterprise, the research commercialisation arm of the University of Cambridge, marked its 15th anniversary with a remarkable series of achievements.

Researchers have developed a new design for computer memory that could both greatly improve performance and reduce the energy demands of internet and communications technologies, which are predicted to consume nearly a third of global electricity within the next ten years.

Cambridge architects have won a public choice award at the London Design Biennale for a prototype home constructed with flexible wooden partition walls which can be shifted to meet the changing needs of residents. The invention aims to reduce waste and carbon while also improving living conditions for those who cannot afford expensive refurbishments.